Novel non-contiguous exon duplication in choroideremia

Novel non-contiguous exon duplication in choroideremia

The importance of establishing a genetic diagnosis in patients with a choroideremia phenotype has been underscored by the advent of gene replacement therapy for this condition. Here, we describe a complex imbalance at the CHM locus in a male patient with classical disease. At the DNA level, this imb...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Edwards, T, Williams, J, Patrício, M, Simunovic, M, Shanks, M, Clouston, P, MacLaren, R
Natura:	Journal article
Lingua:	English
Pubblicazione:	Wiley 2017

Documenti analoghi

The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype
di: Simunovic, M, et al.
Pubblicazione: (2016)

Choroideremia: molecular mechanisms and development of AAV gene therapy
di: Patrício, M, et al.
Pubblicazione: (2018)

Prenylation of rab6a as a potency assay for choroideremia gene therapy
di: Patricio, M, et al.
Pubblicazione: (2017)

Macular hole surgery in patients with end-stage choroideremia
di: Zinkernagel, MS, et al.
Pubblicazione: (2013)

Functional defects in color vision in patients with choroideremia
di: Jolly, J, et al.
Pubblicazione: (2015)

Visual acuity after retinal gene therapy for Choroideremia
di: Edwards, T, et al.
Pubblicazione: (2016)

Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging
di: Jolly, J, et al.
Pubblicazione: (2017)

Retinal degeneration in choroideremia follows an exponential decay function
di: Aylward, J, et al.
Pubblicazione: (2018)

Structural and Functional Characteristics of Color Vision Changes in Choroideremia
di: Jasleen K. Jolly, et al.
Pubblicazione: (2021-10-01)

The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A
di: Patrício, M, et al.
Pubblicazione: (2018)

Structural and functional characteristics of color vision changes in choroideremia
di: Jolly, JK, et al.
Pubblicazione: (2021)

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
di: Xue, K, et al.
Pubblicazione: (2018)

Colour discrimination ellipses in choroideremia
di: Seitz, IP, et al.
Pubblicazione: (2018)

Longitudinal study to assess the quantitative use of fundus autofluorescence for monitoring disease progression in choroideremia
di: Dubis, AM, et al.
Pubblicazione: (2021)

Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
di: Wood, LJ, et al.
Pubblicazione: (2021)

Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial
di: MacLaren, R, et al.
Pubblicazione: (2014)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
di: Han, RC, et al.
Pubblicazione: (2021)

Macular hole surgery in patients with end-stage choroideremia.
di: Zinkernagel, MS, et al.
Pubblicazione: (2013)

A qualitative and quantitative assessment of fundus autofluorescence patterns in patients with choroideremia
di: Jolly, J, et al.
Pubblicazione: (2016)

Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia
di: Xue, K, et al.
Pubblicazione: (2016)

Ocular gene therapy for choroideremia: clinical trials and future perspectives
di: Xue, K, et al.
Pubblicazione: (2018)

Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector.
di: Barnard, A, et al.
Pubblicazione: (2014)

AAV2/2-CBA-REP1 Vector with WPRE Provides Functional Expression of the Transgene in Choroideremia Mouse Knock-Out and Patient Cells
di: Tolmachova, T, et al.
Pubblicazione: (2012)

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
di: Halioua-Haubold, C, et al.
Pubblicazione: (2018)

Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model
di: Halioua-Haubold, C-L, et al.
Pubblicazione: (2019)

Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant
di: Bellingrath, J-S, et al.
Pubblicazione: (2022)

Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial
di: MacLaren, RE, et al.
Pubblicazione: (2023)

Association of a novel intronic variant in RPGR with hypomorphic phenotype of x-linked retinitis pigmentosa
di: Cehajic-Kapetanovic, J, et al.
Pubblicazione: (2020)

Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo
di: Tolmachova, T, et al.
Pubblicazione: (2013)

A detailed in vivo analysis of the retinal nerve fibre layer in choroideremia
di: Fu, D, et al.
Pubblicazione: (2018)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
di: Kane L Greer, et al.
Pubblicazione: (2014-01-01)

Genetic testing for choroideremia
di: Abeshi Andi, et al.
Pubblicazione: (2017-10-01)

Gene therapy for choroideremia using an adeno-associated viral vector encoding Rab escort protein 1: the REGENERATE open-label trial
di: Jasmina Cehajic-Kapetanovic, et al.
Pubblicazione: (2024-05-01)

Multimodal Imaging of Photoreceptor Structure in Choroideremia.
di: Lynn W Sun, et al.
Pubblicazione: (2016-01-01)

Low‐contrast visual acuity versus low‐luminance visual acuity in choroideremia
di: Wood, L, et al.
Pubblicazione: (2020)

Choroideremia: Update On Clinical Features And Emerging Treatments
di: Brambati M, et al.
Pubblicazione: (2019-11-01)

A splice-site variant in FLVCR1 produces retinitis pigmentosa without posterior column ataxia
di: Yusuf, I, et al.
Pubblicazione: (2017)

Retinitis pigmentosa caused by variants in SNRNP200
di: Yusuf, IH, et al.
Pubblicazione: (2019)

Compound dominant-null heterozygosity in a family with RP1-related retinal dystrophy
di: Thomas M.W. Buckley, et al.
Pubblicazione: (2022-12-01)

Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.
di: Tolmachova, T, et al.
Pubblicazione: (2010)